Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey A Kiefer

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Assay and Drug Development Technologies|May 18, 2010
A high-content RNAi-screening assay to identify modulators of cholesterol accumulation in Niemann-Pick type C cellsShilpi Arora, Christian Beaudry, Kristen M Bisanz, et al.
Journal of Surgical Oncology|April 12, 2011
Genomic signatures of cancer: basis for individualized risk assessment, selective staging and therapyFrederick L Baehner, Mark Lee, Michael J Demeure, et al.
Eukaryotic Cell|August 16, 2015
Differences in Host Innate Responses among Coccidioides Isolates in a Murine Model of Pulmonary CoccidioidomycosisEric R G Lewis, Victoria R David, Adina L Doyle, et al.
Cancer Research|March 9, 2005
Osteoprotegerin in prostate cancer bone metastasisEva Corey, Lisha G Brown, Jeffrey A Kiefer, et al.
Neoplasia (New York, N.Y.)|October 13, 2006
Inhibition of androgen-independent prostate cancer by estrogenic compounds is associated with increased expression of immune-related genesIlsa M Coleman, Jeffrey A Kiefer, Lisha G Brown, et al.
International Journal of Cancer|May 3, 2008
Functional evidence implicating S100P in prostate cancer progressionGargi D Basu, David O Azorsa, Jeffrey A Kiefer, et al.
Plos One|June 7, 2017
A prospective pilot study of genome-wide exome and transcriptome profiling in patients with small cell lung cancer progressing after first-line therapyGlen J Weiss, Sara A Byron, Jessica Aldrich, et al.
Journal of Translational Medicine|June 13, 2009
Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancerDavid O Azorsa, Irma M Gonzales, Gargi D Basu, et al.
Oncotarget|May 6, 2015
Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancerLisa Zhang, Yaqin Zhang, Amit Mehta, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 21, 2015
microRNA changes in liver tissue associated with fibrosis progression in patients with hepatitis CKendall R Van Keuren-Jensen, Ivana Malenica, Amanda L Courtright, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Assay and Drug Development Technologies|May 18, 2010
A high-content RNAi-screening assay to identify modulators of cholesterol accumulation in Niemann-Pick type C cellsShilpi Arora, Christian Beaudry, Kristen M Bisanz, et al.
Journal of Surgical Oncology|April 12, 2011
Genomic signatures of cancer: basis for individualized risk assessment, selective staging and therapyFrederick L Baehner, Mark Lee, Michael J Demeure, et al.
Eukaryotic Cell|August 16, 2015
Differences in Host Innate Responses among Coccidioides Isolates in a Murine Model of Pulmonary CoccidioidomycosisEric R G Lewis, Victoria R David, Adina L Doyle, et al.
Cancer Research|March 9, 2005
Osteoprotegerin in prostate cancer bone metastasisEva Corey, Lisha G Brown, Jeffrey A Kiefer, et al.
Neoplasia (New York, N.Y.)|October 13, 2006
Inhibition of androgen-independent prostate cancer by estrogenic compounds is associated with increased expression of immune-related genesIlsa M Coleman, Jeffrey A Kiefer, Lisha G Brown, et al.
International Journal of Cancer|May 3, 2008
Functional evidence implicating S100P in prostate cancer progressionGargi D Basu, David O Azorsa, Jeffrey A Kiefer, et al.
Plos One|June 7, 2017
A prospective pilot study of genome-wide exome and transcriptome profiling in patients with small cell lung cancer progressing after first-line therapyGlen J Weiss, Sara A Byron, Jessica Aldrich, et al.
Journal of Translational Medicine|June 13, 2009
Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancerDavid O Azorsa, Irma M Gonzales, Gargi D Basu, et al.
Oncotarget|May 6, 2015
Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancerLisa Zhang, Yaqin Zhang, Amit Mehta, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 21, 2015
microRNA changes in liver tissue associated with fibrosis progression in patients with hepatitis CKendall R Van Keuren-Jensen, Ivana Malenica, Amanda L Courtright, et al.
Pageof 2